# Silgan Holdings Inc: financial statements, quarterly

SLGN · NYSE · CIK 849869 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slgn.md) · [Financials](/companies/slgn/financials.md) · [Filings](/companies/slgn/filings.md) · [Insiders](/companies/slgn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/slgn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,803](/filings/0000849869-24-000141.md) | [1,340 d](/filings/0001628280-26-012202.md) | [1,317](/filings/0000849869-25-000072.md) | [1,381](/filings/0001628280-25-038677.md) | [1,745](/filings/0001628280-25-049324.md) | [1,411 d](/filings/0001628280-26-012202.md) | [1,467](/filings/0001628280-26-031008.md) | [1,539](/filings/0001628280-26-053967.md) | [2,009](/filings/0001628280-25-049324.md) | [1,469 d](/filings/0001628280-26-012202.md) | [1,561](/filings/0001628280-26-031008.md) | [1,643](/filings/0001628280-26-053967.md) |
| Cost of revenue | $m | [1,517](/filings/0000849869-24-000141.md) | [1,122 d](/filings/0001628280-26-012202.md) | [1,094](/filings/0000849869-25-000072.md) | [1,125](/filings/0001628280-25-038677.md) | [1,452](/filings/0001628280-25-049324.md) | [1,172 d](/filings/0001628280-26-012202.md) | [1,196](/filings/0001628280-26-031008.md) | [1,240](/filings/0001628280-26-053967.md) | [1,681](/filings/0001628280-25-049324.md) | [1,216 d](/filings/0001628280-26-012202.md) | [1,295](/filings/0001628280-26-031008.md) | [1,348](/filings/0001628280-26-053967.md) |
| Gross profit | $m | [286](/filings/0000849869-24-000141.md) | [219 d](/filings/0001628280-26-012202.md) | [223](/filings/0000849869-25-000072.md) | [256](/filings/0001628280-25-038677.md) | [293](/filings/0001628280-25-049324.md) | [239 d](/filings/0001628280-26-012202.md) | [270](/filings/0001628280-26-031008.md) | [299](/filings/0001628280-26-053967.md) | [327](/filings/0001628280-25-049324.md) | [253 d](/filings/0001628280-26-012202.md) | [266](/filings/0001628280-26-031008.md) | [295](/filings/0001628280-26-053967.md) |
| Selling, general and administrative | $m | [84.3](/filings/0000849869-24-000141.md) | [96.6 d](/filings/0001628280-26-012202.md) | [100](/filings/0000849869-25-000072.md) | [108](/filings/0001628280-25-038677.md) | [106](/filings/0001628280-25-049324.md) | [124 d](/filings/0001628280-26-012202.md) | [129](/filings/0001628280-26-031008.md) | [122](/filings/0001628280-26-053967.md) | [122](/filings/0001628280-25-049324.md) | [120 d](/filings/0001628280-26-012202.md) | [131](/filings/0001628280-26-031008.md) | [127](/filings/0001628280-26-053967.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [47.3](/filings/0000849869-23-000150.md) | [42.5 d](/filings/0001628280-26-012202.md) | not reported | not reported | not reported | not reported | [42.9](/filings/0001628280-26-031008.md) | [48.7](/filings/0001628280-26-053967.md) | not reported | not reported | [41.4](/filings/0001628280-26-031008.md) | [47.1](/filings/0001628280-26-053967.md) |
| Income tax | $m | [36.2](/filings/0000849869-24-000141.md) | [19.2 d](/filings/0001628280-26-012202.md) | [17.9](/filings/0000849869-25-000072.md) | [24.4](/filings/0001628280-25-038677.md) | [25.4](/filings/0001628280-25-049324.md) | [4.3 d](/filings/0001628280-26-012202.md) | [20.8](/filings/0001628280-26-031008.md) | [30.4](/filings/0001628280-26-053967.md) | [36.2](/filings/0001628280-25-049324.md) | [35.8 d](/filings/0001628280-26-012202.md) | [22.3](/filings/0001628280-26-031008.md) | [29.2](/filings/0001628280-26-053967.md) |
| Net income | $m | [111](/filings/0000849869-24-000141.md) | [64.4 d](/filings/0001628280-26-012202.md) | [55.2](/filings/0000849869-25-000072.md) | [76.1](/filings/0001628280-25-038677.md) | [100](/filings/0001628280-25-049324.md) | [45.1 d](/filings/0001628280-26-012202.md) | [68.0](/filings/0001628280-26-031008.md) | [88.9](/filings/0001628280-26-053967.md) | [113](/filings/0001628280-25-049324.md) | [18.2 d](/filings/0001628280-26-012202.md) | [63.0](/filings/0001628280-26-031008.md) | [75.8](/filings/0001628280-26-053967.md) |
| Diluted EPS | $ per share | [1.02](/filings/0000849869-24-000141.md) | not reported | [0.52](/filings/0000849869-25-000072.md) | [0.71](/filings/0001628280-25-038677.md) | [0.93](/filings/0001628280-25-049324.md) | not reported | [0.63](/filings/0001628280-26-031008.md) | [0.83](/filings/0001628280-26-053967.md) | [1.06](/filings/0001628280-25-049324.md) | not reported | [0.60](/filings/0001628280-26-031008.md) | [0.72](/filings/0001628280-26-053967.md) |
| Basic EPS | $ per share | [1.02](/filings/0000849869-24-000141.md) | not reported | [0.52](/filings/0000849869-25-000072.md) | [0.71](/filings/0001628280-25-038677.md) | [0.94](/filings/0001628280-25-049324.md) | not reported | [0.64](/filings/0001628280-26-031008.md) | [0.83](/filings/0001628280-26-053967.md) | [1.06](/filings/0001628280-25-049324.md) | not reported | [0.60](/filings/0001628280-26-031008.md) | [0.72](/filings/0001628280-26-053967.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [307](/filings/0000849869-24-000141.md) | [643](/filings/0000849869-25-000029.md) | [309](/filings/0000849869-25-000072.md) | [303](/filings/0001628280-25-038677.md) | [369](/filings/0001628280-25-049324.md) | [823](/filings/0001628280-26-012202.md) | [353](/filings/0001628280-26-031008.md) | [317](/filings/0001628280-26-053967.md) | [389](/filings/0001628280-25-049324.md) | [1,081](/filings/0001628280-26-053967.md) | [435](/filings/0001628280-26-031008.md) | [352](/filings/0001628280-26-053967.md) |
| Current assets | $m | [2,662](/filings/0000849869-24-000141.md) | [2,349](/filings/0000849869-25-000029.md) | [2,376](/filings/0000849869-25-000072.md) | [2,539](/filings/0001628280-25-038677.md) | [2,519](/filings/0001628280-25-049324.md) | [2,523](/filings/0001628280-26-012202.md) | [2,597](/filings/0001628280-26-031008.md) | [3,009](/filings/0001628280-26-053967.md) | [3,112](/filings/0001628280-25-049324.md) | [2,992](/filings/0001628280-26-053967.md) | [2,967](/filings/0001628280-26-031008.md) | [3,294](/filings/0001628280-26-053967.md) |
| Total assets | $m | [7,812](/filings/0000849869-24-000141.md) | [7,611](/filings/0000849869-25-000029.md) | [7,574](/filings/0000849869-25-000072.md) | [7,693](/filings/0001628280-25-038677.md) | [7,747](/filings/0001628280-25-049324.md) | [8,585](/filings/0001628280-26-012202.md) | [8,768](/filings/0001628280-26-031008.md) | [9,410](/filings/0001628280-26-053967.md) | [9,498](/filings/0001628280-25-049324.md) | [9,397](/filings/0001628280-26-053967.md) | [9,322](/filings/0001628280-26-031008.md) | [9,601](/filings/0001628280-26-053967.md) |
| Current liabilities | $m | [1,916](/filings/0000849869-24-000141.md) | [2,312](/filings/0000849869-25-000029.md) | [2,289](/filings/0000849869-25-000072.md) | [2,396](/filings/0001628280-25-038677.md) | [2,306](/filings/0001628280-25-049324.md) | [2,248](/filings/0001628280-26-012202.md) | [2,285](/filings/0001628280-26-031008.md) | [3,135](/filings/0001628280-26-053967.md) | [2,451](/filings/0001628280-25-049324.md) | [2,452](/filings/0001628280-26-053967.md) | [2,358](/filings/0001628280-26-031008.md) | [2,590](/filings/0001628280-26-053967.md) |
| Long-term debt | $m | [3,313](/filings/0000849869-24-000141.md) | [2,546](/filings/0000849869-25-000029.md) | [2,535](/filings/0000849869-25-000072.md) | [2,531](/filings/0001628280-25-038677.md) | [2,554](/filings/0001628280-25-049324.md) | [3,420](/filings/0001628280-26-012202.md) | [3,483](/filings/0001628280-26-031008.md) | [3,115](/filings/0001628280-26-053967.md) | [3,812](/filings/0001628280-25-049324.md) | [3,715](/filings/0001628280-26-053967.md) | [3,672](/filings/0001628280-26-031008.md) | [3,656](/filings/0001628280-26-053967.md) |
| Current portion of debt | $m | [898](/filings/0000849869-24-000141.md) | [880](/filings/0000849869-25-000029.md) | [1,346](/filings/0000849869-25-000072.md) | [1,398](/filings/0001628280-25-038677.md) | [1,254](/filings/0001628280-25-049324.md) | [717](/filings/0001628280-26-012202.md) | [1,145](/filings/0001628280-26-031008.md) | [1,937](/filings/0001628280-26-053967.md) | [1,135](/filings/0001628280-25-049324.md) | [632](/filings/0001628280-26-053967.md) | [988](/filings/0001628280-26-031008.md) | [1,178](/filings/0001628280-26-053967.md) |
| Shareholders' equity | $m | [1,782](/filings/0000849869-24-000141.md) | [1,889](/filings/0001628280-26-012202.md) | [1,900](/filings/0000849869-25-000072.md) | [1,934](/filings/0001628280-25-038677.md) | [2,054](/filings/0001628280-25-049324.md) | [1,990](/filings/0001628280-26-012202.md) | [2,083](/filings/0001628280-26-031008.md) | [2,222](/filings/0001628280-26-053967.md) | [2,272](/filings/0001628280-25-049324.md) | [2,274](/filings/0001628280-26-053967.md) | [2,321](/filings/0001628280-26-031008.md) | [2,379](/filings/0001628280-26-053967.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [216 d](/filings/0000849869-24-000141.md) | [1,079 d](/filings/0001628280-26-012202.md) | [(548)](/filings/0000849869-25-000072.md) | [20.9 d](/filings/0001628280-25-038677.md) | [313 d](/filings/0001628280-25-049324.md) | [936 d](/filings/0001628280-26-012202.md) | [(683)](/filings/0001628280-26-031008.md) | [(221) d](/filings/0001628280-26-053967.md) | [341 d](/filings/0001628280-25-049324.md) | [1,294 d](/filings/0001628280-26-012202.md) | [(800)](/filings/0001628280-26-031008.md) | [(194) d](/filings/0001628280-26-053967.md) |
| Capital expenditure | $m | [55.2 d](/filings/0000849869-24-000141.md) | [53.4 d](/filings/0001628280-26-012202.md) | [75.3](/filings/0000849869-25-000072.md) | [56.2 d](/filings/0001628280-25-038677.md) | [60.6 d](/filings/0001628280-25-049324.md) | [70.8 d](/filings/0001628280-26-012202.md) | [82.9](/filings/0001628280-26-031008.md) | [72.8 d](/filings/0001628280-26-053967.md) | [80.1 d](/filings/0001628280-25-049324.md) | [71.3 d](/filings/0001628280-26-012202.md) | [82.4](/filings/0001628280-26-031008.md) | [64.2 d](/filings/0001628280-26-053967.md) |
| Dividends paid | $m | [19.3 d](/filings/0000849869-24-000141.md) | [19.2 d](/filings/0001628280-26-012202.md) | [21.1](/filings/0000849869-25-000072.md) | [20.3 d](/filings/0001628280-25-038677.md) | [20.3 d](/filings/0001628280-25-049324.md) | [20.3 d](/filings/0001628280-26-012202.md) | [21.9](/filings/0001628280-26-031008.md) | [21.4 d](/filings/0001628280-26-053967.md) | [21.4 d](/filings/0001628280-25-049324.md) | [21.0 d](/filings/0001628280-26-012202.md) | [22.8](/filings/0001628280-26-031008.md) | [22.2 d](/filings/0001628280-26-053967.md) |
| Share repurchases | $m | [153 d](/filings/0000849869-24-000141.md) | [0.1 d](/filings/0001628280-26-012202.md) | [7.7](/filings/0000849869-25-000072.md) | [0.1 d](/filings/0001628280-25-038677.md) | [0.0 d](/filings/0001628280-25-049324.md) | [1.6 d](/filings/0001628280-26-012202.md) | [6.9](/filings/0001628280-26-031008.md) | [0.0 d](/filings/0001628280-26-053967.md) | [59.3 d](/filings/0001628280-25-049324.md) | [8.7 d](/filings/0001628280-26-012202.md) | [7.8](/filings/0001628280-26-031008.md) | [0.0 d](/filings/0001628280-26-053967.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [111](/filings/0000849869-23-000150.md) | [111](/filings/0000849869-24-000069.md) | [110](/filings/0000849869-24-000128.md) | [109](/filings/0000849869-24-000141.md) | [107](/filings/0000849869-25-000072.md) | [107](/filings/0001628280-25-038677.md) | [107](/filings/0001628280-25-049324.md) | [107](/filings/0001628280-26-031008.md) | [107](/filings/0001628280-26-053967.md) | [107](/filings/0001628280-25-049324.md) | [106](/filings/0001628280-26-031008.md) | [106](/filings/0001628280-26-053967.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 105,682,020 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-053967.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.